From 6 to 8 November 2025, the OphtAI team (Evolucare Group) looks forward to seeing you at the AIMO-SISO congress in Italy, at the stand shared with Topcon Italy, a global player in ophthalmic imaging. Join us there to discover our latest innovations in artificial intelligence applied to ophthalmology.
🔍 Major advances in the diagnosis of retinal diseases
OphtAI will present its cutting-edge solutions for the automated detection of eye conditions such as:
- Diabetic retinopathy (detection and grading)
- Glaucoma
- Age-related macular degeneration (AMD) and drusen
- Naevi
- Retinal vein occlusion (CRVO + BRVO)
- Macular hole, epiretinal membrane
- Cataracts, severe myopia, retinitis pigmentosa
- Hypertensive retinopathy
- Laser photocoagulation scars, pigment migration
- Alteration of the retinal pigment epithelium
- Normal/abnormal eye (patented technology)
- MIDD
These innovations are the result of close collaboration between Evolucare, AP-HP, UBO and Adcis, guaranteeing powerful and clinically validated algorithms.
💡 MyOphtAI: simplicity, autonomy, efficiency
In response to the increasing pressure on healthcare professionals, OphtAI offers MyOphtAI, a monthly subscription service with no commitment, including:
- Free trial
- Unlimited use
- Zero handling, zero clicks: files are sorted automatically
👉 Test MyOphtAI for free and discover a new way of working that is smoother and more efficient.
🤝 A robust ecosystem of partners and integrators
OphtAI relies on a network of recognised technology partners and integrators:
- Topcon, Optomed, Crystalvue, Umami View
- Oplus, Téo, Area
This complementarity ensures optimal interoperability and rapid adoption in the field.
📍 Come and experience OphtAI at our stand no. 30.
On site, you can:
- Discover real-world use cases
- Talk to our AI specialists
- Test our solutions in real-world situations
A unique opportunity to understand how AI can strengthen the work of healthcare professionals, improve early diagnosis and reduce inequalities in access to eye care.